New drug applications approved by US FDA as of 01-15 June 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Early identification of dysphagia following acute stroke appears to have significant protective health benefits, such as minimizing the risks of pneumonia, mortality, overall dependency, and hospitalization duration, according to the results of a systematic review and meta-analysis.
Patients with epilepsy who use antiepileptic drugs (AEDs) are at higher risk of major cardiovascular (CV) events compared with the general population, and this risk does not vary between enzyme- and nonenzyme-inducing AEDs, as reported in a study.
Wrist-worn devices, particularly those that measure temperature, may help monitor sleep in older adults living with dementia (OAWD), according to a recent study. Nevertheless, current technologies seem to fall short, as they are easily disrupted by broken sleep patterns and body movements.
Getting patients with suspected large-vessel occlusion (LVO) stroke to undergo immediate angiography instead of the standard CT scan speeds up time stroke treatment and improves 90-day functional outcomes, according to the ANGIOCAT study presented at the ISC 2021 Meeting.
Outcomes after stroke thrombectomy were no better with tissue plasminogen activator (tPA) withheld in the MR CLEAN-NO IV trial, suggesting that the practice of giving thrombolytics still holds in stroke.